首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >The effect of chitosan nanoparticle to hepatic cells -Is chitosan nanoparticle an enhancer of AKT1/mTOR pathway?
【24h】

The effect of chitosan nanoparticle to hepatic cells -Is chitosan nanoparticle an enhancer of AKT1/mTOR pathway?

机译:壳聚糖纳米粒子对肝细胞的影响 - 壳聚糖纳米粒子AKT1 / mTOR途径的增强剂吗?

获取原文

摘要

In this study, CCL-13 and HepG2 cells were served as cell models for the uptake of chitosan nanoparticles. To evaluate early responses of CCL-13 and HepG2 cells to chitosan nanoparticles, a mass spectrometry-based profiling system was adopted for assessing characteristic proteins that were expressed due to the interactions of CCL-13 and HepG2 cells with chitosan nanoparticles. Through the investigation, various proteins that influence the early responses of CCL-13 and HepG2 cells on chitosan nanoparticle were found, and, as we know, some of them have not been reported in the study of cell-nanoparticle interactions.
机译:在该研究中,CCL-13和HepG2细胞用作壳聚糖纳米粒子摄取的细胞模型。为了评估CCL-13和HepG2细胞对壳聚糖纳米颗粒的早期反应,采用质谱法的分析系统用于评估由于CCL-13和HepG2细胞与壳聚糖纳米粒子的相互作用而表达的特征蛋白。通过调查,发现各种影响CCL-13和HepG2细胞在壳聚糖纳米粒子上的早期反应的蛋白质,并且如我们所知,其中一些尚未在细胞纳米粒子相互作用的研究中报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号